Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis

被引:22
作者
Ethuin, F
Delarche, C
Gougerot-Pocidalo, MA
Eurin, B
Jacob, L
Chollet-Martin, S
机构
[1] CHU Xavier Bichat, Immunol Lab, F-75018 Paris, France
[2] CHU Xavier Bichat, INSERM, U479, F-75018 Paris, France
[3] Hop St Louis, Dept Anesthesie Reanimat, Paris, France
关键词
D O I
10.1097/01.LAB.0000087589.37269.FC
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Paradoxically, the host response to severe sepsis may lead to immunosuppression, thereby favoring nosocomial infections. We examined the role of the two IL-12 isoforms, bioactive IL-12p7O and regulatory IL-12p4O, in 16 patients with severe sepsis. We compared the capacity of purified blood and alveolar phagocytes [polymorphonuclear neutrophils (PMN) and monocytes/macrophages] to secrete each isoform. Blood monocytes had normal basal secretions. In contrast, a marked imbalance was observed after ex vivo stimulation by lipopolysaccharide plus IFN-gamma, with significantly lower IL-12p7O production and higher IL-12p4O production. Conversely, stimulated IL-12p4O production by the patients' blood PMN tended to be impaired, as was their cell-surface beta2 integrin and L-selectin expression, known as markers of cell activation. In the patient's bronchoalveolar lavage fluid, the production of both IL-12 isoforms after ex vivo stimulation was significantly lower with alveolar macrophages than with autologous blood monocytes and significantly higher with alveolar PMN than with autologous blood PMN. This sheds new light on the potential role of PMN in local modulation of inflammation, via secretion of the anti-inflammatory IL-12 p40 subunit. The imbalance between the bioactive and regulatory IL-12 isoforms, which is probably designed to control excessive inflammation, may also make septic patients more susceptible to nosocomial infection.
引用
收藏
页码:1353 / 1360
页数:8
相关论文
共 44 条
[1]   IL-12: The role of p40 versus p75 [J].
Abdi, K .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 56 (01) :1-11
[2]  
Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30
[3]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]  
Camoglio L, 2002, EUR J IMMUNOL, V32, P261, DOI 10.1002/1521-4141(200201)32:1<261::AID-IMMU261>3.0.CO
[6]  
2-X
[7]   INTERLEUKIN-12 PRODUCTION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
DANDREA, A ;
MA, XJ ;
TRINCHIERI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) :1-5
[8]   Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon:: a review [J].
Cavaillon, JM ;
Adib-Conquy, M ;
Cloëz-Tayarani, I ;
Fitting, C .
JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (02) :85-93
[9]   Excess production of interleukin-12 subunit p40 stimulated by the virulence plasmid of Salmonella enterica serovar Typhimurium in the early phase of infection in the mouse [J].
Chang, CC ;
Ou, JT .
MICROBIAL PATHOGENESIS, 2002, 32 (01) :15-25
[10]   Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS [J].
CholletMartin, S ;
Jourdain, B ;
Gibert, C ;
Elbim, C ;
Chastre, J ;
GougerotPocidalo, MA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :594-601